University of Alabama in Birmingham — Birmingham, Alabama

University of Alabama in Birmingham is a clinical research site located in Birmingham, Alabama, United States 35294.

Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.

University of Alabama in Birmingham has participated in 12 clinical trials with 8 currently active.

Therapeutic areas: Traumatic Brain Hemorrhage, Lymphoma, Alzheimers Disease.

Sponsors: InfraScan, Inc., Otsuka Pharmaceutical Development & Commercialization, Inc., Washington University School of Medicine.

Sponsor Feasibility Report

Trust Score: 77/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Alabama in Birmingham?

University of Alabama in Birmingham has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Alabama in Birmingham conducted?

University of Alabama in Birmingham has 12 clinical trials on record, with 8 currently active. Their work covers Traumatic Brain Hemorrhage, Lymphoma, Alzheimers Disease.

Is University of Alabama in Birmingham accredited by Crixeo Health?

Yes — University of Alabama in Birmingham holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about University of Alabama in Birmingham?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.